Nanomedx is a biotechnology firm that specializes in nanomedicine, developing multifunctional carbon-based nanoparticles.
Nanomedx has raised $485K in total funding. The most recent round was Grant. The last funding was announced in June 2025.
Nanomedx's investors include MTPConnect.
Nanomedx is headquartered in Sydney, Australia.
Nanomedx is a biotechnology firm that specializes in nanomedicine, developing multifunctional carbon-based nanoparticles.
Nanomedx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanomedx — Funding & Investors." VCBacked, June 20, 2025, https://www.vcbacked.co/company/nanomedx. Accessed August 14, 2026.
VCBacked. (2025). Nanomedx — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nanomedx
{{cite web |title=Nanomedx — Funding & Investors |url=https://www.vcbacked.co/company/nanomedx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated